| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010242 |
| Receipt No. | R000011756 |
| Official scientific title of the study | Comparison of additive effect of omega-3 fatty acid or ezetimibe in combination with statins on the reduction of small dense LDL in patients with coronary artery disease |
| Date of disclosure of the study information | 2013/03/15 |
| Last modified on | 2018/06/28 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Comparison of additive effect of omega-3 fatty acid or ezetimibe in combination with statins on the reduction of small dense LDL in patients with coronary artery disease | |
| Title of the study (Brief title) | Comparison of additive effect of omega-3 fatty acid or ezetimibe in combination with statins on the reduction of small dense LDL in patients with coronary artery disease | |
| Region |
|
|
| Condition | |||
| Condition | Uncontrolled dyslipiemic patients with coronary artery disease under statin use | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate additive effects of omega-3 fatty acid or ezetimibe in combination with statins on the reduction of small dense LDL in patients with coronary artery disease |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change in small dense LDL |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Omega-3 fatty | |
| Interventions/Control_2 | Ezetimib | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)adults over 20 years old
2)HbA1c less than 9% 3)Change in HbA1c plus/minus 1% during last 3 months |
|||
| Key exclusion criteria | 1)TG>=400mg/dL
2)Patients receiving insulin therapy 3)Pregnant woman or possibly pregnant woman 4)Patients having allergy for study drug 5)Active hepatitis or liver cirrhosis 6)Serum creatinine >2mg/dL 7)Patients suffered from acute coronary syndrome or stroke last 3 months 8)Secondary hyperlipidemia, drug-induced hyperlipidemia, familial hyperlipidemia |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Ito |
| Organization | Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences |
| Division name | Cardiovascular Medicine |
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama |
| TEL | 086-235-7351 |
| miyoshit@cc.okayama-u.ac.jp | |
| Public contact | |
| Name of contact person | Toru Miyoshi |
| Organization | Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences |
| Division name | Cardiovascular Medicine |
| Address | 2-5-1 Shikada-cho Kita-ku Okayama |
| TEL | 086-235-7351 |
| Homepage URL | |
| miyoshit@cc.okayama-u.ac.jp | |
| Sponsor | |
| Institute | Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences, Department of Cardiovascular Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences, Department of Cardiovascular Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011756 |